Zalicus Inc (ZLCS.OQ)

ZLCS.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
1 Aug 2013
Price Change (% chg)

$0.01 (+2.13%)
Prev Close
$0.48
Open
$0.48
Day's High
$0.49
Day's Low
$0.48
Volume
62,287
Avg. Vol
112,574
52-wk High
$1.54
52-wk Low
$0.43

ZLCS.OQ

Chart for ZLCS.OQ

About

Zalicus Inc. (Zalicus) is a biopharmaceutical company that discovers and developsl treatments for patients suffering from pain and immuno-inflammatory diseases. The Company has a portfolio of clinical-stage product candidates targeting pain and immuno-inflammatory diseases and have entered into multiple revenue-generating... (more)

Overall

Beta: 2.35
Market Cap (Mil.): $61.41
Shares Outstanding (Mil.): 127.26
Dividend: --
Yield (%): --

Financials

  ZLCS.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.32 -- --
ROI: -80.96 -2.58 18.76
ROE: -112.14 -2.66 19.59
Search Stocks

Competitors

  Price Change
Covidien plc (COV.N) $63.02 +1.39
Actavis Inc (ACT.N) $135.56 +1.29
Johnson & Johnson (JNJ.N) $94.11 +0.61
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.45 +0.28
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Pfizer Inc. (PFE.N) $29.33 +0.10
Abbott Laboratories (ABT.N) $36.95 +0.32
Bayer AG (BAYGn.DE) €89.43 +2.08
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$472.00
Provider: Pechala's Reports
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks